Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Sep 19, 2006

Washington State University Extends Licenses from GeneGo

  • Washington State University Tri-cities extended its license of GeneGo’s MetaCore. The latest version of the product, release 4.0, provides researchers with a multilevel analysis of experimental data with respect to functional processes, diseases, and consensus pathways via one click, according to the company.

    “The software helped us to interpret proteomic data from irradiated cells and to identify pathways responsible for cytokine release following radiation exposure,” explains John Miller, Ph.D., associate professor, Washington State University Tri-Cities. “Understanding these pathways is important for both radiation protection standards and effective use of radiation therapy to treat cancer.”



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »